Details of the Drug | DrugMAP

General Information of Drug (ID: DMJAXTY)

Drug Name

PF-06650833

Indication

Disease Entry	ICD 11	Status	REF
Lupus	4A40	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C18H20FN3O4
Canonical SMILES: CCC1C(NC(=O)C1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N
InChI: 1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1
InChIKey: JKDGKIBAOAFRPJ-ZBINZKHDSA-N

Cross-matching ID

PubChem CID: 118414016
CAS Number: 1817626-54-2
UNII: S3F315JJXI
DrugBank ID: DB15143
TTD ID: D07NUL

References

1	ClinicalTrials.gov (NCT02224651) Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions. U.S. National Institutes of Health.